Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00433706 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Image Guided Radiation Therapy For Prostate Cancer

StatusCompleted
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Amendment history

  1. Minor

    Study Status, Study Design, References

    v4

  2. Minor

    Trial status: Recruiting to Completed

    Enrollment target: estimated 520 to confirmed 470; Primary completion date: Oct 2012; Completion date: Sep 2007 to Nov 2012; and 3 more

    Show all 7 changes in this update
    • Minor Trial status: Recruiting to Completed
    • Minor Enrollment target: estimated 520 to confirmed 470
    • Minor Primary completion date: Oct 2012
    • Minor Completion date: Sep 2007 to Nov 2012
    • Minor Interventions: Control position by 3DOBI before the fraction (Procedure) to Control position by 3DOBI before the fraction (Procedure), Standard imaging (Procedure)
    • Minor Site details revised
    • Minor Study arms: 0 to 2

    Study Status, Sponsor/Collaborators, Study Design, Arms and Interventions, Contacts/Locationsv3

  3. Notable

    Trial status: Not Yet Recruiting to Recruiting

    Start date: Mar 2007 to Jun 2007; Completion date: Sep 2007; Site details revised

    Study Status, Study Design, Contacts/Locationsv2

  4. Minor

    Study First Submitted

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
During the 7 to 8 weeks of conformal radiotherapy for prostate carcinoma, the prostate has an intra-pelvic motion which is not detectable by the conventional portal imaging. This prostate motion may lead to a mistargeting, which possibly decreases the local control. On the other hand, the new 3D on board imaging (3D OBI) allows to localize the target but is expensive. The cost/effectiveness ratio is not well established, as well as the frequency of using such imaging during the course of radiation.
Trial Details
NCT Number NCT00433706
Lead Sponsor Gustave Roussy, Cancer Campus, Grand Paris
Collaborators: National Cancer Institute, France
Conditions Prostate Cancer
Enrollment 470 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov